299 related articles for article (PubMed ID: 18584583)
1. Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.
Dietze GJ; Henriksen EJ
J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):75-88. PubMed ID: 18584583
[TBL] [Abstract][Full Text] [Related]
2. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.
Henriksen EJ; Jacob S
J Cell Physiol; 2003 Jul; 196(1):171-9. PubMed ID: 12767053
[TBL] [Abstract][Full Text] [Related]
3. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
4. Acute exercise causes an enhancement of tissue renin-angiotensin system in the kidney in rats.
Maeda S; Iemitsu M; Jesmin S; Miyauchi T
Acta Physiol Scand; 2005 Sep; 185(1):79-86. PubMed ID: 16128700
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training.
Bradley SJ; Kingwell BA; Canny BJ; McConell GK
Metabolism; 2007 Oct; 56(10):1405-11. PubMed ID: 17884453
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
Rouyer O; Zoll J; Daussin F; Damgé C; Helms P; Talha S; Rasseneur L; Piquard F; Geny B
Exp Physiol; 2007 Nov; 92(6):1047-56. PubMed ID: 17675412
[TBL] [Abstract][Full Text] [Related]
7. Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE).
Xiao HD; Fuchs S; Frenzel K; Teng L; Bernstein KE
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):137-45. PubMed ID: 15104531
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
Clerk LH; Vincent MA; Barrett EJ; Lankford MF; Lindner JR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1804-9. PubMed ID: 17911341
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of kinins: historical and recent developments.
Rett K; Wicklmayr M; Dietze GJ
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S57-9. PubMed ID: 1697362
[TBL] [Abstract][Full Text] [Related]
10. [Angiotensin-converting enzyme and its physiological role].
Eliseeva IuE
Vopr Med Khim; 2001; 47(1):43-54. PubMed ID: 11385998
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects.
Boschmann M; Kreuzberg U; Engeli S; Adams F; Franke G; Klaua S; Scholze J; Weidinger G; Luft FC; Sharma AM; Jordan J
Horm Metab Res; 2006 May; 38(5):323-9. PubMed ID: 16718629
[TBL] [Abstract][Full Text] [Related]
12. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
13. [The current concept of the renin-angiotensin system].
Ibarra-Rubio ME; Pedraza-Chaverrí J
Rev Invest Clin; 1993; 45(2):165-77. PubMed ID: 8337545
[TBL] [Abstract][Full Text] [Related]
14. The kallikrein/kinin system in the pathogenesis of hypertension in diabetes mellitus.
Wicklmayr M; Rett K; Baldermann H; Dietze G
Diabete Metab; 1989; 15(5 Pt 2):306-10. PubMed ID: 2693148
[TBL] [Abstract][Full Text] [Related]
15. Local umbilical cord blood renin-angiotensin system.
Goker H; Haznedaroglu IC; Beyazit Y; Aksu S; Tuncer S; Misirlioglu M; Bayramoglu F; Kekilli M; Büyükasik Y; Sayinalp N; Ozcebe O; Dundar S; Mollamahmutoglu L
Ann Hematol; 2005 May; 84(5):277-81. PubMed ID: 15645231
[TBL] [Abstract][Full Text] [Related]
16. [Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
Dotsenko VL; Demidova TIu; Neshkova EA; Ametov AS; Iarovaia GA
Vopr Med Khim; 1998; 44(2):203-12. PubMed ID: 9634724
[TBL] [Abstract][Full Text] [Related]
17. Vascular angiotensin pathways: a new therapeutic target.
Dzau VJ
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S9-16. PubMed ID: 2485070
[TBL] [Abstract][Full Text] [Related]
18. AT(1) receptors and control of blood pressure: the kidney and more..
Crowley SD; Gurley SB; Coffman TM
Trends Cardiovasc Med; 2007 Jan; 17(1):30-4. PubMed ID: 17210476
[TBL] [Abstract][Full Text] [Related]
19. Insulin and blood pressure regulation.
Gans RO; Donker AJ
J Intern Med Suppl; 1991; 735():49-64. PubMed ID: 2043223
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of ACE inhibitors.
Berne C
J Intern Med Suppl; 1991; 735():119-25. PubMed ID: 2043220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
